March 10, 2017 12:00am

Financial results also known as (AKA) earnings is a ‘scorecard’ of public stem, cell, gene and regenerative therapy's companies.

 

The current LPS (loss per share) standings reflect the universes’ investing status; then add in their cash position for a better snapshot!

By analyzing these comparisons, investors can begin to gauge the financial health versus the scientific opportunity and whether or not it deserves their investment.


COMPANY SYMBOL NET INCOME Q4/16 LOSS Q4/16 LPS Q4/16 CASH 
Aduro Biotech, Inc. ADRO   -$29.6 M -$0.44 $361.9 M
Applied Genetic Technologies AGTC +$2.1 M   +$0.11 $159.1 M
Asterias Biotherapeutics AST        
Athersys, Inc. ATHX   -$7.1 M -$0.10 $34.7 M
Adverum Biotechnologies, Inc. ADVM   -$22.4 M -$0.54 $222.2 M
AxoGen, Inc. AXGN   -$3.2 M -$0.10 $30 M
Bellicum Pharmaceuticals, Inc. BLCM   -$19.9 M -$0.74 $113.4 M
BioLife Solutions, Inc. BLFS   -$3.3 M -$0.26 $1.4 M
Biostage, Inc. BSTG   -$3.34 M -$0.20 $2.94 M
BioTime, Inc. BTX   -$5.1 M -$0.05 $22.1 M
bluebird bio BLUE   -$71.33 M -$1.88 $884.8 M
Brainstorm Cell Therapeutics Inc. BCLI        
Caladrius Biosciences. CLBS   -$6 M -$0.73

$14.7 M

$75 M from PCT sale

Capricor CAPR   -$4.5 M -$0.21 $16.2 M
Cellectis CLLS  

-€12.5 M

-€0.35

€276.2 M

Cesca Therapeutics, Inc KOOL   -$3.4 M N/A $4.89 M
Cytori Therapeutics, Inc. CYTX        
Fate Therapeutics, Inc. FATE   -$7.94 M -$0.21 $92.1 M
Fibrocell Science, Inc. FCSC   -$15.29 M (FY16) -$0.39 (FY16) $17.5 M
Histogenics Corporation HSGX   -$11.1 M -$0.61 (diluted) $31.9 M
ImmunoCellular Therapeutics, Ltd. IMUC   -$6.3 M -$1.36 $11.4 M
International Stem Cell ISCO        
Intrexon Corporation XON   -$44.1 M -$0.26 $243.2 M
Juno Therapeutics, Inc. JUNO   -$52.8 M -$0.51 $922.3 M
Kite Pharma, Inc. KITE   -$84.9 M -$1.70 $414.4 M
Mesoblast Limited MBLTY   -$20.5 M -$5.27 $55.6 M
MiMedx Group, Inc MDXG +$5.5 M   +$0.05 $34.4 M
Neuralstem, Inc.  CUR        
Northwest Biotherapeutics, Inc. NWBO        
Opexa Therapeutic, Inc. OPXA        
Organovo Holdings, Inc. ONVO        
Osiris Therapeutics, Inc. OSIR        
Pluristem Therapeutics, Inc. PSTI        
ReNeuron Group PLC RENE.L        
Regenxbio RGNX   -$19.6 M -$0.74 $159 M
Sangamo Biosciences, Inc. SGMO   -$9.6 M -$0.14 $142.8 M
Spark Therapeutics, Inc. ONCE   -$123.7 M -$4.29 $333.1 M
Stemline Therapeutics, Inc. STML        
uniQure N.V. QURE   -$14.7 M 
Verastem, Inc. VSTM        
Vericel Corporation VCEL   -$6.2 M -$0.34 $23 M
VistaGen Therapeutics, Inc. VTGN